Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

A new emergency contraceptive has been approved by the FDA that is effective up to 5 days after unprotected intercourse. Ulipristal acetate is a selective progesterone receptor modulator with partial agonist and partial antagonistic effects. It is licensed from Laboratoire HRA Pharma in France and marketed by Watson Pharma as Ella™.

Ulipristal Acetate Tablets (Ella™)